however, since then, four states (California, New Hampshire, Pennsylvania, and South Carolina) have eliminated coverage of GLP-1s for obesity treatment, likely reflecting recent state budget challenges and the significant costs associated with coverage
I really appreciate this
State Medicaid Coverage of GLP-1s for Obesity Treatment (as of August 2024) KFF found that as of August 2024, 13 state Medicaid programs covered GLP-1s for obesity treatment within their fee-for-service programs
Weeks 48: The This Is Working Phase If youve stayed consistent, this is where many clients feel like theyve hit a groove
Who Is a Candidate for B12 Injection
[19] These licensed treatments offer a far safer, evidence-based alternative to unlicensed investigational compounds